The potential to prevent or treat illness and advance scientific knowledge is a strong driver for investment in medical (biomedical and health) research. Exploring the scale of these impacts helps in the evaluation of investment opportunities and should inform policy decision.
In parallel, returns to the national economy are an important consideration when evaluating the worth of public (government and charity) research investment. By estimating the effects of publicly funded research on the UK economy, policy decisions can be facilitated and accountability reporting strengthened.
This policy briefing published by the Policy Institute at Kings College London explores the key findings of new research looking at the economic spillover of publicly funded health and medical research and provides an interpretation for policy makers